Evonik Venture Capital generates strategic value and growth opportunities through investing and partnering with innovative start-up companies. With a fund size of €250 million, Evonik Venture Capital has made about 40 investments since 2012, both direct and fund investments. The investment scope ranges from early stage to growth stage with an investment volume of up to €15 million per portfolio company.

Evonik Venture Capital has offices in Germany, the USA and China and invests in innovative technologies and disruptive business models in the fields of Nutrition & Care, Specialty Additives and Smart Materials, as well as enabling digital technologies.